Search

NIAID awarded $2.5 million in grants to 12 institutes for research on bacteriophage therapy—its first series focused exclusively on the approach. The projects address phage resistance, biofilms, host specificity, delivery, engineering and c

Armata Pharmaceuticals and Innoviva have announced a $25 Million investment to support Armata's phage cocktail development.

Prof. Daniel Nelson's lab at University of Maryland has been awarded funds to study endolysins as a treatment for acne caused by C. acnes.

Prof. Daniel Nelson's lab at University of Maryland has been awarded funds to study endolysins as a treatment for acne caused by C. acnes.

Armata Pharmaceuticals and Innoviva have announced a $25 Million investment to support Armata's phage cocktail development.

PhagoMed attended the Biotech Showcase 2020 this week in San Francisco, and announced it is looking to raise $16 million from US and European investors to bring its phage products to the clinic (watch this interview with CEO Alexander Belcr

PhagoMed attended the Biotech Showcase 2020 this week in San Francisco, and announced it is looking to raise $16 million from US and European investors to bring its phage products to the clinic (watch this interview with CEO Alexander Belcr

Adaptive Phage Therapeutics was awarded a $10.2-million contract with the US Department of Defense. The funds will go toward developing PhageBank™️, the company's personalized phage therapy system, including conducting a clinical trial.

Adaptive Phage Therapeutics was awarded a $10.2-million contract with the US Department of Defense. The funds will go toward developing PhageBank™️, the company's personalized phage therapy system, including conducting a clinical trial.

In collaboration with researchers at Brunel University London, a new UK synthetic biology company called CC Bio is developing phage lysins to target bacterial vaginosis caused by Gardnerella vaginalis. They've just received £250,000 in fund

In collaboration with researchers at Brunel University London, a new UK synthetic biology company called CC Bio is developing phage lysins to target bacterial vaginosis caused by Gardnerella vaginalis. They've just received £250,000 in fund

Another publicly-traded phage company is now on the stock market! This week, the phage/microbiome biotech company BiomX completed its merger with Chardan Healthcare, and the combined company (BiomX Inc.) started trading on the New York Stoc

Another publicly-traded phage company is now on the stock market! This week, the phage/microbiome biotech company BiomX completed its merger with Chardan Healthcare, and the combined company (BiomX Inc.) started trading on the New York Stoc

Big news! NIH (NIAID) has put out a request for applications for translational phage research to inform phage therapy! If you're interested in applying and are looking for particular expertise to add to your proposal, or have expertise to s

Big news! NIH (NIAID) has put out a request for applications for translational phage research to inform phage therapy! If you're interested in applying and are looking for particular expertise to add to your proposal, or have expertise to s

Associate Professor Ruby Lin of the Westmead Institute for Medical Research (last week's Capsid & Tail guest writer! has been awarded a grant from BGI Australia to build Australia's first "phage biobank"! The phage bank will give Australian

Associate Professor Ruby Lin of the Westmead Institute for Medical Research (last week's Capsid & Tail guest writer! has been awarded a grant from BGI Australia to build Australia's first "phage biobank"! The phage bank will give Australian

Polish company Proteon Pharmaceuticals has been awarded a 2.9 million Euro grant from the European Regional Development Fund to develop phages to fight bacterial infections in fish farming (aquaculture). The grant will help Proteon improve

Polish company Proteon Pharmaceuticals has been awarded a 2.9 million Euro grant from the European Regional Development Fund to develop phages to fight bacterial infections in fish farming (aquaculture). The grant will help Proteon improve

PhagoMed, an Austrian phage therapy company, announced this week that it’s received 1.5 million Euro in additional investment!